Shelter Pharma Limited has submitted a regulatory disclosure to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure concerns the receipt of significant international purchase orders.
Order Details
- Entity Awarding Order: Genet International
- Nature of Order: Normal course of business
- Geographic Classification: International entity, international order
- Products: Veterinary Feed Supplements
- FEEDMIN BOLUS: 2,000 boxes at USD 1.35 per box (USD 2,700.00)
- REGULIN BOLUS: 2,500 boxes at USD 1.35 per box (USD 3,375.00)
- Lactocal Gel: 1,200 pieces at USD 2.80 per piece (USD 3,360.00)
- BUTA-B BOLUS: 1,500 boxes at USD 1.90 per box (USD 2,850.00)
- Total Order Value: USD 12,285
- Execution Timeline: To be executed within mutually agreed timelines as per purchase order schedule
Transaction Relationships
- The promoter/promoter group/group companies have no interest in Genet International
- The transaction does not constitute related party transactions
- The transaction is not conducted at arm's length basis
Expected Impact
The execution of these orders is expected to:
- Further strengthen the company's global presence
- Enhance its export business
- Contribute positively to revenue growth
- Support overall business expansion